GH1 and neoplasm: In a recent retrospective study conducted by Nguyen Quoc et al. (31), no association was found between the timing of GH replacement therapy after childhood-onset CP treatment and the risk of recurrence or tumor progression, suggesting that GH replacement therapy can be initiated 6 months after the last treatment for CP.